Log in to save to my catalogue

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot form...

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot form...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69076684

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany

About this item

Full title

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany

Publisher

New Zealand

Journal title

PharmacoEconomics, 2005-01, Vol.23 (S1), p.49-61

Language

English

Formats

Publication information

Publisher

New Zealand

More information

Scope and Contents

Contents

Schizophrenia is one of the most expensive psychiatric conditions because of high direct and indirect costs associated with the nature of the illness, its resistance to treatment and the consequences of relapse. Long-acting risperidone is a new formulation of an atypical antipsychotic drug that also offers the improvements in compliance associated...

Alternative Titles

Full title

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_69076684

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69076684

Other Identifiers

ISSN

1170-7690

E-ISSN

1179-2027

DOI

10.2165/00019053-200523001-00005

How to access this item